GLP1Zoom Reference Card
Compounded Semaglutide
g
No manufacturer savings card available — compounded products are prepared by licensed 503A/503B pharmacies, not Novo Nordisk.
NOT FDA-approved as finished drug. Compounded semaglutide is permitted under FDA pharmacy compounding rules but is not reviewed for safety, efficacy or manufacturing quality by the FDA. The brand-name product Wegovy® is FDA-approved.
Molecule
semaglutide
Regulatory status
NOT FDA-approved as finished product (compounded under 503A/503B oversight)
Telehealth providers offering this molecule